ICT&health December 17, 2025
Philips strengthens its position in cardiac care with the acquisition of US-based SpectraWAVE, a pioneer in intravascular imaging and physiological assessment of coronary arteries using AI. The company brings technologies such as HyperVue and X1-FFR, which provide physicians with fast, detailed images and physiological data of the coronary arteries. With this acquisition, Philips is expanding its portfolio and aims to achieve better outcomes for more cardiac patients.
“We are strongly committed to image-guided therapy and are expanding our portfolio in the coronary intervention segment with the addition of SpectraWAVE’s AI-driven innovations in high-detail intravascular imaging and angio-based physiological assessment, enabling us to deliver better care to more people,” said Roy Jakobs, CEO of Royal Philips.
SpectraWAVE’s intravascular imaging and physiological...
Today's Sponsors
Today's Sponsor